$LTES
Leet Technology Inc Stock $ltes

$ltes Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000168316823009117 Filed on December 28, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2023 Q2
Revenue	$138.0K	$34.29K	$95.88K
YoY Change	283.41%	-32.94%	125.31%
Cost Of Revenue	$186.1K	$155.3K	$156.8K
YoY Change	-45.33%	-28.37%	-27.32%
Gross Profit	-$48.12K	-$121.0K	-$60.94K
YoY Change	-84.19%	-26.97%	-64.82%
Gross Profit Margin	-34.87%	-352.97%	-63.56%
Selling, General & Admin	$346.0K	$194.3K	$277.6K
YoY Change	-10.1%	-44.82%	-36.5%
% of Gross Profit
Research & Development	-$53.26K	$8.952K	$8.957K
YoY Change	-682.08%	-1.38%	-1.22%
% of Gross Profit
Depreciation & Amortization	$28.24K	$2.800K	$2.710K
YoY Change	-121.79%	-75.5%	-70.73%
% of Gross Profit
Operating Expenses	$292.7K	$203.2K	$286.6K
YoY Change	-25.7%	-43.73%	-35.79%
Operating Profit	-$340.8K	-$324.2K	-$347.5K
YoY Change	-51.2%	-38.46%	-43.9%
Interest Expense	$47.83K	$0.00	$1.386K
YoY Change	-83.91%
% of Operating Profit
Other Income/Expense, Net	$38.58K	$16.87K	$36.66K
YoY Change	56.7%	-103.58%	254.2%
Pretax Income	-$254.4K	-$307.4K	-$310.8K
YoY Change	-34.21%	-69.22%	-48.97%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$253.7K	-$307.5K	-$310.6K
YoY Change	-33.74%	-69.21%	-49.01%
Net Earnings / Revenue	-183.87%	-896.69%	-323.94%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	151.1M shares	151.1M shares	152.1M shares
Diluted Shares Outstanding		151.1M shares	152.1M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.58K	$14.85K	$62.62K
YoY Change	-54.96%	28.35%	2610.82%
Cash & Equivalents	$16.58K	$14.85K	$62.62K
Short-Term Investments
Other Short-Term Assets	$15.04K	$12.59K	$12.95K
YoY Change	28.44%	-57.48%	-51.19%
Inventory
Prepaid Expenses
Receivables	$16.78K	$40.94K	$28.16K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$48.40K	$68.39K	$103.7K
YoY Change	-76.4%	-48.34%	61.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$83.93K	$109.6K	$113.0K
YoY Change	-32.02%	-8.63%	-17.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$83.93K	$109.6K	$115.7K
YoY Change	-36.66%	-48.27%	-47.49%
TOTAL ASSETS
Total Short-Term Assets	$48.40K	$68.39K	$103.7K
Total Long-Term Assets	$83.93K	$109.6K	$115.7K
Total Assets	$132.3K	$178.0K	$219.5K
YoY Change	-60.8%	-48.3%	-22.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$60.38K	$482.4K	$488.0K
YoY Change	-88.61%	-19.63%	-21.44%
Accrued Expenses	$736.2K	$200.3K	$293.9K
YoY Change	93.81%	249.67%	387.57%
Deferred Revenue	$313.6K	$392.5K	$285.4K
YoY Change	15.81%	35.69%	8.54%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.056M	$3.709M	$3.537M
YoY Change	41.81%	123.78%	-41.56%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.056M	$3.709M	$3.537M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$4.056M	$3.709M	$3.537M
YoY Change	41.81%	123.78%	-41.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.33M	-$11.99M	-$11.58M
YoY Change	16.6%	18.66%	27.27%
Common Stock	$15.11K	$15.11K	$15.11K
YoY Change	-1.18%	-1.18%	-1.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$9.578M	-$9.092M	-$8.783M
YoY Change
Total Liabilities & Shareholders Equity	$132.3K	$178.0K	$219.5K
YoY Change	-60.8%	-48.3%	-22.86%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$253.7K	-$307.5K	-$310.6K
YoY Change	-33.74%	-69.21%	-49.01%
Depreciation, Depletion And Amortization	$28.24K	$2.800K	$2.710K
YoY Change	-121.79%	-75.5%	-70.73%
Cash From Operating Activities	-$286.0K	-$305.0K	-$330.9K
YoY Change	-55.22%	-32.75%	82.3%
INVESTING ACTIVITIES
Capital Expenditures	-$20.00	-$30.00	-$30.00
YoY Change	-84.62%	-118.75%	-99.27%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Cash From Investing Activities	$20.00	$30.00	$30.00
YoY Change	-99.99%	-100.04%	-100.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	343.7K	250.6K	370.1K
YoY Change	-39.42%	-36.95%	35.56%
NET CHANGE
Cash From Operating Activities	-286.0K	-305.0K	-330.9K
Cash From Investing Activities	20.00	30.00	30.00
Cash From Financing Activities	343.7K	250.6K	370.1K
Net Change In Cash	57.70K	-54.37K	39.26K
YoY Change	-64.67%	-60.76%	-11647.06%
FREE CASH FLOW
Cash From Operating Activities	-$286.0K	-$305.0K	-$330.9K
Capital Expenditures	-$20.00	-$30.00	-$30.00
Free Cash Flow	-$286.0K	-$304.9K	-$330.8K
YoY Change	-55.21%	-32.79%	86.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001586495
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue		usd
CY2023Q2	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55053
	dei	Entity Registrant Name EntityRegistrantName	LEET TECHNOLOGY INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3590850
	dei	Entity Address Address Line1 EntityAddressAddressLine1	805, 8th Floor
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Menara Mutiara Majestic
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Jalan Othman, Petaling Jaya
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46000
	dei	Entity Address City Or Town EntityAddressCityOrTown	Selangor
	dei	Entity Address Country EntityAddressCountry	MY
	dei	City Area Code CityAreaCode	603
	dei	Local Phone Number LocalPhoneNumber	7783 1636
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	151096262	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14851	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36808	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40941	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	156585	usd
CY2023Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	12594	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	11712	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	68386	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	205105	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	109580	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	123458	usd
CY2023Q3	LTES	Operating Lease Right Of Use Asset Current OperatingLeaseRightOfUseAssetCurrent	0	usd
CY2022Q4	LTES	Operating Lease Right Of Use Asset Current OperatingLeaseRightOfUseAssetCurrent	9046	usd
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	109580	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	132504	usd
CY2023Q3	us-gaap	Assets Assets	177966	usd
CY2022Q4	us-gaap	Assets Assets	337609	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	482403	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	530198	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	200317	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	379872	usd
CY2023Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	398337	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	413443	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	392538	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	270795	usd
CY2023Q3	LTES	Due To Related Party Current DueToRelatedPartyCurrent	2235471	usd
CY2022Q4	LTES	Due To Related Party Current DueToRelatedPartyCurrent	1157166	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	99624	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9046	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3709066	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2860144	usd
CY2023Q3	us-gaap	Liabilities Liabilities	3709066	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2860144	usd
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	5567953	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	5284837	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	100	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	100	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	151096262	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	151096262	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	152899640	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	152899640	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	15110	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	15290	usd
CY2023Q3	LTES	Common Stock To Be Cancelled CommonStockToBeCancelled	-0	usd
CY2022Q4	LTES	Common Stock To Be Cancelled CommonStockToBeCancelled	100	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2773081	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2773001	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	106131	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14021	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11986142	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10578195	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-9091720	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-7803925	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	-7333	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-3447	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9099053	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7807372	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	177966	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	337609	usd
CY2023Q3	us-gaap	Revenues Revenues	34288	usd
CY2022Q3	us-gaap	Revenues Revenues	51127	usd
	us-gaap	Revenues Revenues	179424	usd
	us-gaap	Revenues Revenues	115988	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	155313	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	216837	usd
	us-gaap	Cost Of Revenue CostOfRevenue	457209	usd
	us-gaap	Cost Of Revenue CostOfRevenue	586782	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-121025	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	-165710	usd
	us-gaap	Gross Profit GrossProfit	-277785	usd
	us-gaap	Gross Profit GrossProfit	-470794	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8952	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9077	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26890	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27142	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	194264	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	352059	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	847193	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1306852	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	203216	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	361136	usd
	us-gaap	Operating Expenses OperatingExpenses	874083	usd
	us-gaap	Operating Expenses OperatingExpenses	1333994	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-324241	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-526846	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1151868	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1804788	usd
CY2023Q3	us-gaap	Interest Income Operating InterestIncomeOperating	0	usd
CY2022Q3	us-gaap	Interest Income Operating InterestIncomeOperating	0	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	0	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	77	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	-0	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	-0	usd
	us-gaap	Interest Expense InterestExpense	5546	usd
	us-gaap	Interest Expense InterestExpense	-0	usd
CY2023Q3	LTES	Recovery Written Off Of Accounts Receivable RecoveryWrittenOffOfAccountsReceivable	418	usd
CY2022Q3	LTES	Recovery Written Off Of Accounts Receivable RecoveryWrittenOffOfAccountsReceivable	0	usd
	LTES	Recovery Written Off Of Accounts Receivable RecoveryWrittenOffOfAccountsReceivable	-32365	usd
	LTES	Recovery Written Off Of Accounts Receivable RecoveryWrittenOffOfAccountsReceivable	0	usd
CY2023Q3	LTES	Foreign Exchange Gain Currency Transaction Gain Loss Before Tax ForeignExchangeGainCurrencyTransactionGainLossBeforeTax	1877	usd
CY2022Q3	LTES	Foreign Exchange Gain Currency Transaction Gain Loss Before Tax ForeignExchangeGainCurrencyTransactionGainLossBeforeTax	0	usd
	LTES	Foreign Exchange Gain Currency Transaction Gain Loss Before Tax ForeignExchangeGainCurrencyTransactionGainLossBeforeTax	17114	usd
	LTES	Foreign Exchange Gain Currency Transaction Gain Loss Before Tax ForeignExchangeGainCurrencyTransactionGainLossBeforeTax	0	usd
CY2023Q3	LTES	Cybersecurity Service Income CybersecurityServiceIncome	14501	usd
CY2022Q3	LTES	Cybersecurity Service Income CybersecurityServiceIncome	0	usd
	LTES	Cybersecurity Service Income CybersecurityServiceIncome	29403	usd
	LTES	Cybersecurity Service Income CybersecurityServiceIncome	0	usd
CY2023Q3	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	0	usd
CY2022Q3	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	0	usd
	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	0	usd
	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	10239	usd
CY2023Q3	LTES	Loss On Settlement With Related Parties LossOnSettlementWithRelatedParties	-0	usd
CY2022Q3	LTES	Loss On Settlement With Related Parties LossOnSettlementWithRelatedParties	471860	usd
	LTES	Loss On Settlement With Related Parties LossOnSettlementWithRelatedParties	-0	usd
	LTES	Loss On Settlement With Related Parties LossOnSettlementWithRelatedParties	471860	usd
CY2023Q3	LTES	Loss On Early Redemption Of Convertible Promissory Note LossOnEarlyRedemptionOfConvertiblePromissoryNote	-0	usd
CY2022Q3	LTES	Loss On Early Redemption Of Convertible Promissory Note LossOnEarlyRedemptionOfConvertiblePromissoryNote	-0	usd
	LTES	Loss On Early Redemption Of Convertible Promissory Note LossOnEarlyRedemptionOfConvertiblePromissoryNote	28340	usd
	LTES	Loss On Early Redemption Of Convertible Promissory Note LossOnEarlyRedemptionOfConvertiblePromissoryNote	-0	usd
CY2023Q3	LTES	Sundry Income Expense Net SundryIncomeExpenseNet	73	usd
CY2022Q3	LTES	Sundry Income Expense Net SundryIncomeExpenseNet	0	usd
	LTES	Sundry Income Expense Net SundryIncomeExpenseNet	42578	usd
	LTES	Sundry Income Expense Net SundryIncomeExpenseNet	111	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	16869	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-471860	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	22844	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-461433	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-307372	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-998706	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1129024	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2266221	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-307372	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-998706	usd
	us-gaap	Profit Loss ProfitLoss	-1129024	usd
	us-gaap	Profit Loss ProfitLoss	-2266221	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	85	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4193	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-307457	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-998706	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1124831	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2266221	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	93682	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	265198	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	120459	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	531723	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-213690	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-733508	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1008565	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1734498	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	151096262	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	151096262	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	152899640	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	152899640	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	151787179	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	151787179	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	152899640	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	152899640	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4769184	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	33249	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-658415	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5394350	usd
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	233276	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-609100	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5770174	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	265198	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-998706	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6503682	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7807372	usd
CY2023Q1	us-gaap	Dividends Dividends	94372	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5956	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-510821	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8418521	usd
CY2023Q2	us-gaap	Dividends Dividends	94372	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	32733	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-310831	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8790991	usd
CY2023Q3	us-gaap	Dividends Dividends	94372	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	93682	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-307372	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9099053	usd
	us-gaap	Profit Loss ProfitLoss	-1129024	usd
	us-gaap	Profit Loss ProfitLoss	-2266221	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8519	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	29370	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	131961	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2525	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
	LTES	Amortization Noncash Financing Cost AmortizationNoncashFinancingCost	3020	usd
	LTES	Amortization Noncash Financing Cost AmortizationNoncashFinancingCost	0	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	32364	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
	LTES	Loss On Early Redemption Of Convertible Promissory Note LossOnEarlyRedemptionOfConvertiblePromissoryNote	28340	usd
	LTES	Loss On Early Redemption Of Convertible Promissory Note LossOnEarlyRedemptionOfConvertiblePromissoryNote	0	usd
	LTES	Loss On Settlement With Related Partiy LossOnSettlementWithRelatedPartiy	0	usd
	LTES	Loss On Settlement With Related Partiy LossOnSettlementWithRelatedPartiy	471860	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	3664	usd
	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	-0	usd
	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	10239	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-77784	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	78367	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	1665	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	7531	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-15734	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	115556	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-191032	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	11169	usd
	LTES	Accrued Compensation Payable To Officers And Directors AccruedCompensationPayableToOfficersAndDirectors	10728	usd
	LTES	Accrued Compensation Payable To Officers And Directors AccruedCompensationPayableToOfficersAndDirectors	60155	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	144042	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	309005	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-4859	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1030133	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1234477	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1973	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9509	usd
	LTES	Disposal Of Cash From Subsidiaries DisposalOfCashFromSubsidiaries	-0	usd
	LTES	Disposal Of Cash From Subsidiaries DisposalOfCashFromSubsidiaries	11012	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	-0	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	226055	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1973	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-246576	usd
	LTES	Advances From Repayment To Director AdvancesFromRepaymentToDirector	-830	usd
	LTES	Advances From Repayment To Director AdvancesFromRepaymentToDirector	613	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	1169678	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	1326148	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	113300	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	-0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1057208	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1325535	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-47059	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	143898	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-21957	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11620	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36808	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23192	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14851	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11572	usd
	LTES	Issuance Of Series B Convertible Preferred Stock In Exchange Of Balances Due To Related Parties IssuanceOfSeriesBConvertiblePreferredStockInExchangeOfBalancesDueToRelatedParties	0	usd
	LTES	Issuance Of Series B Convertible Preferred Stock In Exchange Of Balances Due To Related Parties IssuanceOfSeriesBConvertiblePreferredStockInExchangeOfBalancesDueToRelatedParties	5190465	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14851	usd
CY2023Q3	LTES	Working Capital WorkingCapital	-3640680	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11986142	usd
	us-gaap	Profit Loss ProfitLoss	-1129024	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zwLL3RsS2ZXe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86F_zrtuk4msDgJ9">Use of estimates and assumptions</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing these unaudited condensed consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements during the period reported. Actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q3	us-gaap	Revenues Revenues	34288	usd
CY2022Q3	us-gaap	Revenues Revenues	51127	usd
	us-gaap	Revenues Revenues	179424	usd
	us-gaap	Revenues Revenues	115988	usd
CY2022	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	20000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	160706	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	169210	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	51126	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	45752	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	109580	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	123458	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8519	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	29370	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9046	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9046	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9046	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	6725	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	4978	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	7000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	151096262	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	151096262	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	152899640	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	152899640	shares
	us-gaap	Net Income Loss NetIncomeLoss	-1124831	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2266221	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	151787179	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	151787179	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	152899640	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	152899640	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	LTES	Due To Related Party Current And Noncurrent DueToRelatedPartyCurrentAndNoncurrent	2235471	usd
CY2022Q4	LTES	Due To Related Party Current And Noncurrent DueToRelatedPartyCurrentAndNoncurrent	1157166	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	50845	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001683168-23-009117-index-headers.html	Edgar Link	pending
0001683168-23-009117-index.html	Edgar Link	pending
0001683168-23-009117.txt	Edgar Link	pending
0001683168-23-009117-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
leetlogo.jpg	Edgar Link	pending
leet_ex3101.htm	Edgar Link	pending
leet_ex3102.htm	Edgar Link	pending
leet_ex3201.htm	Edgar Link	pending
leet_ex3202.htm	Edgar Link	pending
leet_i10q-093023.htm	Edgar Link	pending
ltes-20230930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
ltes-20230930_pre.xml	Edgar Link	unprocessable
ltes-20230930_cal.xml	Edgar Link	unprocessable
leet_i10q-093023_htm.xml	Edgar Link	completed
ltes-20230930_lab.xml	Edgar Link	unprocessable
ltes-20230930_def.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LTES
Leet Technology Inc Stock $ltes

2023 Q4 Form 10-Q Financial Statement

#000168316823009117 Filed on December 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LTES Leet Technology Inc Stock $ltes

2023 Q4 Form 10-Q Financial Statement

#000168316823009117 Filed on December 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LTES
Leet Technology Inc Stock $ltes